LPL Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $204K | Buy |
84,916
+15,133
| +22% | +$29.5K | ﹤0.01% | 5747 |
|
|
2026
Q1 | $109K | Sell |
69,783
-17,274
| -20% | -$25.1K | ﹤0.01% | 5659 |
|
|
2025
Q4 | $100K | Sell |
87,057
-4,201
| -5% | -$5.77K | ﹤0.01% | 5593 |
|
|
2025
Q3 | $123K | Sell |
91,258
-13,175
| -13% | -$15K | ﹤0.01% | 5465 |
|
|
2025
Q2 | $98.8K | Buy |
104,433
+33,476
| +47% | +$21.7K | ﹤0.01% | 5270 |
|
|
2025
Q1 | $32.7K | Buy |
70,957
+13,950
| +24% | +$8.8K | ﹤0.01% | 5205 |
|
|
2024
Q4 | $42.1K | Sell |
57,007
-6,028
| -10% | -$7.27K | ﹤0.01% | 5123 |
|
|
2024
Q3 | $99K | Buy |
63,035
+1,950
| +3% | +$3.47K | ﹤0.01% | 4891 |
|
|
2024
Q2 | $103K | Sell |
61,085
-28,878
| -32% | -$51.8K | ﹤0.01% | 4738 |
|
|
2024
Q1 | $216K | Buy |
89,963
+45,969
| +104% | +$98.8K | ﹤0.01% | 4455 |
|
|
2023
Q4 | $67.3K | Buy |
43,994
+17,000
| +63% | +$20.2K | ﹤0.01% | 4614 |
|
|
2023
Q3 | $29.4K | Buy |
26,994
+2,007
| +8% | +$3.52K | ﹤0.01% | 4575 |
|
|
2023
Q2 | $57.2K | Buy |
24,987
+4,255
| +21% | +$11.3K | ﹤0.01% | 4409 |
|
|
2023
Q1 | $50.4K | Hold |
20,732
| – | – | ﹤0.01% | 4299 |
|
|
2022
Q4 | $39.6K | Buy |
20,732
+32
| +0.2% | +$68 | ﹤0.01% | 4299 |
|
|
2022
Q3 | $50K | Hold |
20,700
| – | – | ﹤0.01% | 4230 |
|
|
2022
Q2 | $39K | Buy |
20,700
+9,700
| +88% | +$18.5K | ﹤0.01% | 4267 |
|
|
2022
Q1 | $23K | Buy |
+11,000
| New | +$30.5K | ﹤0.01% | 4113 |
|
|
2019
Q3 | – | Sell |
-36,931
| Closed | -$232K | – | 3343 |
|
|
2019
Q2 | $232K | Sell |
36,931
-466
| -1% | -$2.79K | ﹤0.01% | 2916 |
|
|
2019
Q1 | $208K | Buy |
37,397
+7,136
| +24% | +$43.3K | ﹤0.01% | 2918 |
|
|
2018
Q4 | $201K | Sell |
30,261
-3,359
| -10% | -$27.2K | ﹤0.01% | 2807 |
|
|
2018
Q3 | $359K | Buy |
33,620
+375
| +1% | +$4.3K | ﹤0.01% | 2522 |
|
|
2018
Q2 | $399K | Buy |
33,245
+4,073
| +14% | +$41.7K | ﹤0.01% | 2394 |
|
|
2018
Q1 | $250K | Buy |
29,172
+7,426
| +34% | +$68.7K | ﹤0.01% | 2782 |
|
|
2017
Q4 | $215K | Sell |
21,746
-6,474
| -23% | -$67.3K | ﹤0.01% | 2763 |
|
|
2017
Q3 | $347K | Buy |
28,220
+3,906
| +16% | +$57.7K | ﹤0.01% | 2246 |
|
|
2017
Q2 | $400K | Sell |
24,314
-6,326
| -21% | -$98K | ﹤0.01% | 2054 |
|
|
2017
Q1 | $435K | Buy |
+30,640
| New | +$455K | ﹤0.01% | 1920 |
|
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$13K | – | 2911 |
|
|
2015
Q1 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 2762 |
|
|
2014
Q4 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 2701 |
|
|
2014
Q3 | $18K | Buy |
2,000
+571
| +40% | +$6.1K | ﹤0.01% | 2669 |
|
|
2014
Q2 | $16K | Buy |
+1,429
| New | +$15.3K | ﹤0.01% | 2663 |
|
Other funds holding LXRX
CLOS
GCP
PAM
SOW
LPL Financial's LXRX Position: Q2 2026 in Review
LPL Financial increased its Lexicon Pharmaceuticals (LXRX) stake by 22% in Q2 2026, buying an estimated $29.5K and bringing the position to 84,916 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #5747.
LPL Financial first reported a position in LXRX in Q2 2014 and has held it in 32 quarters since. The position peaked at $435K in Q1 2017. 51 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.
- LPL Financial held 84,916 shares of Lexicon Pharmaceuticals worth $204K as of Q2 2026.
- LPL Financial bought 15,133 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $29.5K.
- Lexicon Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5747 holding.
- LPL Financial first reported a position in Lexicon Pharmaceuticals in Q2 2014 and has held it in 32 quarters since.
- LPL Financial's Lexicon Pharmaceuticals position peaked at $435K in Q1 2017.
- 51 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.